H

Healthpeak Properties Inc
F:HC5

Watchlist Manager
Healthpeak Properties Inc
F:HC5
Watchlist
Price: 19.2 EUR Market Closed
Market Cap: 13.5B EUR
Have any thoughts about
Healthpeak Properties Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one HC5 stock under the Base Case scenario is 31.11 EUR. Compared to the current market price of 19.2 EUR, Healthpeak Properties Inc is Undervalued by 38%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HC5 Relative Value
Base Case
31.11 EUR
Undervaluation 38%
Relative Value
Price
H
Worst Case
Base Case
Best Case

Valuation Multiples

5.5
P/S
P/S
Price to Sales
5.5
vs History
84
vs Industry
Median 3Y
6.1
Median 5Y
7.8
Industry
3.6
Forward
5.2
More Details
45.4
P/E
P/E
Price to Earnings
45.4
vs History
31
vs Industry
Median 3Y
35.4
Median 5Y
37.1
Industry
16.7
Forward
52.4
More Details
13.8
P/OCF
P/OCF
Price to OCF
13.8
vs History
74
vs Industry
Median 3Y
14.8
Median 5Y
15.9
Industry
10.9
More Details
30.1
P/FCFE
P/FCFE
Price to FCFE
30.1
vs History
19
vs Industry
Median 3Y
18.9
Median 5Y
-8.7
Industry
13.3
More Details
1.6
P/B
P/B
Price to Book Value
1.6
vs History
80
vs Industry
Median 3Y
1.8
Median 5Y
1.9
Industry
0.8
More Details
8.8
EV/S
EV/S
Enterprise Value to Sales
8.8
vs History
79
vs Industry
Median 3Y
9.5
Median 5Y
11
Industry
6.6
Forward
8.3
More Details
13.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
13.5
vs History
90
vs Industry
Median 3Y
15.1
Median 5Y
18.6
Industry
11.9
More Details
14.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
14.4
vs History
90
vs Industry
Median 3Y
16.1
Median 5Y
18.8
Industry
15.8
Forward
14.6
More Details
38.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
38.1
vs History
90
vs Industry
Median 3Y
44.2
Median 5Y
58.8
Industry
19
Forward
57.4
More Details
22
EV/OCF
EV/OCF
Enterprise Value to OCF
22
vs History
68
vs Industry
Median 3Y
22.6
Median 5Y
23.8
Industry
18.5
More Details
48.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
48.1
vs History
23
vs Industry
Median 3Y
-16.5
Median 5Y
-17.1
Industry
20.1
More Details
1.2
EV/IC
EV/IC
Enterprise Value to IC
1.2
vs History
71
vs Industry
Median 3Y
1.2
Median 5Y
1.3
Industry
0.7
More Details

Multiples Across Competitors

HC5 Competitors Multiples
Healthpeak Properties Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Healthpeak Properties Inc
F:HC5
13.4B EUR 5.5 45.4 14.4 38.1
US
Welltower Inc
NYSE:WELL
77B USD 10.3 84.1 32.8 78.6
US
Ventas Inc
NYSE:VTR
24.5B USD 5.1 -368.9 17.8 52.3
US
Physicians Realty Trust
NYSE:DOC
14B USD 5.5 45.4 14.4 38.2
US
Omega Healthcare Investors Inc
NYSE:OHI
10.1B USD 10 29 16.4 24.7
US
Healthcare Realty Trust Inc
NYSE:HR
6.4B USD 4.8 -22.7 14.6 211.6
US
Healthcare Trust Of America Inc
F:HT01
5.3B EUR 7.1 58.8 18.6 47.7
US
CareTrust REIT Inc
NYSE:CTRE
4.7B USD 17.2 46.9 20.5 26.9
US
Sabra Health Care REIT Inc
NASDAQ:SBRA
4B USD 5.9 41.3 15.5 26.3
US
National Health Investors Inc
NYSE:NHI
3B USD 9.2 23.6 16.3 22.4
BE
Aedifica NV
XBRU:AED
2.7B EUR 8.1 24 18.6 18.8
P/E Multiple
Earnings Growth P/E to Growth
US
H
Healthpeak Properties Inc
F:HC5
Average P/E: 44.3
45.4
-37%
N/A
US
Welltower Inc
NYSE:WELL
84.1
309%
0.3
US
Ventas Inc
NYSE:VTR
Negative Multiple: -368.9 N/A N/A
US
Physicians Realty Trust
NYSE:DOC
45.4
-37%
N/A
US
Omega Healthcare Investors Inc
NYSE:OHI
29
85%
0.3
US
Healthcare Realty Trust Inc
NYSE:HR
Negative Multiple: -22.7 N/A N/A
US
H
Healthcare Trust Of America Inc
F:HT01
58.8
N/A N/A
US
C
CareTrust REIT Inc
NYSE:CTRE
46.9
417%
0.1
US
Sabra Health Care REIT Inc
NASDAQ:SBRA
41.3
1 210%
0
US
National Health Investors Inc
NYSE:NHI
23.6
11%
2.1
BE
Aedifica NV
XBRU:AED
24
889%
0

See Also

Summary
HC5 intrinsic value, competitors valuation, and company profile.
DCF Valuation
HC5 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HC5 stock valuation using valuation multiples.
Wall Street Estimates
HC5 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HC5 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.